Dextran sulfate inhibits acute Toxoplama gondii infection in pigs by Kentaro Kato et al.
RESEARCH Open Access
Dextran sulfate inhibits acute Toxoplama
gondii infection in pigs
Kentaro Kato1,2*, Yuho Murata1, Noriyuki Horiuchi3, Atsuko Inomata2, Mohamad Alaa Terkawi1, Akiko Ishiwa1,2,
Yohsuke Ogawa4, Shinya Fukumoto1, Fumikazu Matsuhisa3 and Kenji Koyama3
Abstract
Background: Toxoplasma gondii is a highly prevalent protozoan that can infect all warm-blooded animals,
including humans. Its definitive hosts are Felidae and its intermediate hosts include various other mammals and
birds, including pigs. It is found in the meat of livestock which is a major source of human infection. Hence the
control of toxoplasmosis in pigs is important for public health. We previously showed that dextran sulfate (DS),
especially DS10 (dextran sulfate MW 10 kDa), is effective against T. gondii infection both in vitro and in mice. In this
study, we asked whether DS affects T. gondii infection of pigs, one of the main animal sources of toxoplasmosis
transmission to humans.
Methods: Fourteen-day-old male pigs (n = 10) were infected with T. gondii and then immediately treated with
different doses of DS10; clinical, pathological, and immunological analyses were performed 5 days post-infection.
Results: DS10 had an inhibitory effect on toxoplasmosis in pigs. Intravenous injection of DS10 prevented the
symptoms of toxoplasmosis and reduced the parasite burden and inflammation induced by T. gondii infection.
High-dose DS10 (500 μg per head) caused reversible hepatocellular degeneration of the liver; middle-dose DS10
(50 μg per head) was effective against toxoplasmosis in pigs without causing this side effect.
Conclusions: Our data suggest that middle-dose DS10 led to minimal clinical symptoms of T. gondii infection and
caused little hepatocellular degeneration in our pig model, thereby demonstrating its potential as a new treatment
for toxoplasmosis. These data should be very beneficial to those interested in the control of toxoplasmosis in pigs.
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Background
Toxoplasma gondii is a highly prevalent protozoan that
can infect all warm-blooded animals, including humans.
Its definitive hosts are Felidae and its intermediate hosts
include various other mammals and birds, including
pigs. In these intermediate hosts, T. gondii has two asex-
ual stages: the tachyzoite stage and the bradyzoite stage.
Tachyzoites cause toxoplasmosis in fetuses and immuno-
compromised patients. Bradyzoites multiply within
tissue cysts that are found in the meat of livestock,
especially pork and mutton, and they are a major source
of human infection [1]. Hence the control of toxoplas-
mosis in pigs is important for public health.
Pigs acquire T. gondii by ingesting oocysts from a
contaminated environment or tissue cysts from infected
animals [2]. To date, there have been relatively few stud-
ies of T. gondii in pigs and, as a result, there is little
information regarding the pathology of pigs infected
with T. gondii. One study examined piglets infected with
a low virulent cyst-forming strain of T. gondii and
analyzed the immunological response to the infection
[3]. Another study evaluated the safety of vaccination
and the persistence and distribution of the T. gondii
stages within tissues following vaccination [4]. Mouse
bioassays, histopathology, and PCR have also been used
to detect T. gondii infection in tissues from experimen-
tally infected pigs [5]. The pathogenicity in 7-week-old
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pigs to five different T. gondii strains of various host
species origin was compared after intravenous inocula-
tion of tachyzoites in another study [6]. Pigs infected
with tachyzoites, tissue cysts, or oocysts showed dose-
dependent clinical effects such as loss of appetite, fever,
and poor general condition [7]. Another study examined
whether vaccination with the RH strain could induce
protective immunity to oral challenge with T. gondii
oocysts [8]. These researchers also studied the distribu-
tion of tissue cysts in porcine tissues, by feeding the
oocysts of four strains of T. gondii to pigs [9].
With regard to the development of anti-Toxoplasma
drugs, previous studies have shown that the attachment
of Toxoplasma to the host cell is mediated by interac-
tions with sulfated glycosaminoglycans (GAGs) on the
host cell, and that excess soluble GAGs inhibit this
attachment to various cell lineages [10]. Monteiro
showed that the ability of T. gondii to infect Chinese
hamster ovary (CHO) cells deficient in sialic acids was
reduced by 26.9 % compared with wild-type cells,
indicating that sialic acid is critical for attachment and
invasion of T. gondii [11]. Micronemal proteins (MICs)
are released onto the parasite surface before host cell in-
vasion and play important roles in host cell recognition,
attachment, and penetration. Structural analysis of
TgMIC1 revealed a novel cell-binding motif called the
microneme adhesive repeat region (MARR), which pro-
vides a specialized structure for glycan discrimination
[12]. Carbohydrate microarray analyses have shown that
TgMIC13 and TgMIC1 share a preference for α2-3- over
α2-6-linked sialyl-N-acetyllactosamine sequences [13].
P104, a PAN/apple domain-containing protein expressed
at the apical end of the extracellular parasite, functions
as a ligand in the attachment of T. gondii to chondroitin
sulfate or other receptors on the host cell, facilitating in-
vasion by the parasite [14]. In our previous study, we
assessed the effects of several GAGs on toxoplasmosis
and revealed that dextran sulfate MW 10 kDa (DS10)
was the most effective in inhibiting the acute infection
in vitro. Moreover, DS10 also had an inhibitory effect on
T. gondii infection of mice [15].
In the present study, we examined the pathological
condition of pigs infected with T. gondii. The effects of
DS10 on Toxoplasma infection of pigs were assessed via
host clinical, pathological, and immunological analyses.
Methods
Cells and parasites
Vero cells were cultured in Dulbecco’s Modified Eagle’s
Medium (DMEM) supplemented with 5 % fetal calf
serum (FCS), L-glutamine, penicillin, streptomycin and
0.15 % NaHCO3. Tachyzoites of the wild-type T.gondii
RH strain were maintained in monolayers of Vero cells
in DMEM supplemented with 1 % FCS, L-glutamine,
penicillin, streptomycin and 0.15 % NaHCO3 [15].
Animal experiments
Ethical approval
All animal work has been conducted according to the
national guidelines of Japan. The protocol was approved
by the Committee on the Ethics of Animal Experiments
of Obihiro University of Agriculture and Veterinary
(Permit Number: 25–26).
Pig infection experiments were performed at the
Research Institute for Animal Science in Biochemistry &
Toxicology. Fourteen-day-old male pigs (n = 10) were
used in this study. They were kept under specific
pathogen-free conditions before purchase. Tachyzoites
of the wild-type T. gondii RH strain were collected from
infected Vero cells by using the syringe-lysis method
and then filtered through a 5-μm pore filter [15].
Parasites were counted with a hemocytometer. Pigs were
divided into the following five groups: the DS-H group
(A and B), DS-M group (C and D), DS-L group (E and
F), TG-control group (G and H), and DS-control group
(I and J) (Fig. 1). The pigs of the DS-H group, DS-M
group, and DS-L group were injected intravenously with
1 × 106 tachyzoites in 1 ml of DMEM. At the same time,
Dextran Sulfate MW 10 kDa (DS10) was administered
intravenously to the pigs of the DS-H, DS-M, and DS-L
groups; the DS-H group was injected with of DS10 500
μg per head, the DS-L group received 50 μg per head,
and the DS-L group received 5 μg per head. The pigs of
the TG-control group were injected with 1 × 106 tachy-
zoites only, and the pigs of the DS-control group were
injected with 0.5 g of DS10 and DMEM but no tachy-
zoites. We monitored the temperature and body weight
of the pigs and collected sera from them until 5 days
post-infection. Then, the pigs were euthanized and sub-
mitted for necropsy. Samples of liver, spleen, kidney,
heart, lung, hilar lymph node, colon and brain were
collected for qRT-PCR and pathological analyses.
Antibody response
Toxoplasma antibody titers were determined using Toxo
Check-MT according to the manufacturer’s instructions
(Eiken, Tokyo, Japan).
Serum biochemistry
Serum samples for biochemical analysis were examined
with a clinical chemistry automated analyzer (Toshiba
Medical Systems Co., Tochigi, Japan). Concentrations of
total protein, sodium, potassium, chloride, albumin,
glucose, cholesterols, aspartate transaminase, γ-glutamyl
transpeptidase, creatinine and blood urea nitrogen in the
serum samples were measured by using specific detec-
tion reagents (Denka Seiken, Tokyo, Japan).
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Quantitative real-time polymerase chain reaction (qRT–PCR)
Organs including spleen, liver, kidney, lungs, lymph
nodes, heart and brain were harvested, placed in Trizol
Reagent (Invitrogen, Carlsbad, CA, USA) and lysed for
RNA and genomic DNA extraction in accordance with
the manufacturer’s instructions. Total RNA was isolated
by using the ReliaPrep Miniprep System (Promega,
Madison, WI, USA) and then reverse transcribed to
first-strand cDNA (Invitrogen, Carlsbad, CA, USA)
following the manufacturer’s instructions. Parasite bur-
den was determined in genomic DNA samples (adjusted
to 50 ng/μl) by using an ABI Prism Genetic Analyzer
(Applied Biosystems, Carlsbad, CA, USA) with SYBR
Green (Applied Biosystems) and specific primers [15].
The expression of cytokines was analyzed by means of
qRT-PCR with the specific primers listed in the
(Additional file 1: Table S1). The primers for qRT-PCR
were designed with the Primer Express software (Applied
Biosystems). Specific gene expression was normalized to
the expression of ubiquitin by using swine β-actin as the
housekeeping gene. Relative gene expression was calcu-
lated by using the 2−ΔΔCt method.
Pathological analyses of experimental pigs
Collected samples were fixed in 15 % neutral buffered
formalin, embedded in paraffin, sectioned at 5 μm, and
stained with hematoxylin and eosin (HE) for histological
examination. For objective observation, major lesions
were counted and the number of lesion per unit area
was calculated. The counted number was divided by the
tissue area of the organ on a glass slide, which was mea-
sured by using image analysis software (BZX_Analyzer,
version 1.1.0.1, Keyence Corporation, Osaka, Japan) to
obtain the number of foci per unit area. The sections of
liver and lung were also subjected to immunohistochem-
ical examination. These examinations were performed
using a rabbit polyclonal anti-T gondii antibody (1:50
dilution, Abcam, CA, USA, ab15170) as the primary
antibody and the simple stain MAX-PO polymer reagent
(Nichirei Bioscience, Tokyo, Japan) after autoclave
pretreatment for antigen retrieval (121 °C for 20 min in
0.01 M citrate buffer, pH 6.0). For objective analyses, the
number of positive reactions per unit area was calculated.
Positive reactions were identified and counted according
to the following criteria by two pathologists, who were not
part of the live pig experiments or the necropsies and
were blinded to the group name and pig ID: independent
brown round to oval substance was counted as 1, regard-
less of its size; macrophages containing fine positive
granules were counted as 1, regardless of the amount
contained. The number of organisms was then divided by
the tissue area of the organ on the glass slide.
Fig. 1 Body temperatures of the experimental pigs. Changes in body temperatures (°C) of experimental pigs were calculated and the days
post-infection are shown. Pigs A and B were injected with T. gondii RH strain and 0.5 mg of dextran sulfate. Pigs C and D were injected with
T. gondii RH strain and 0.05 mg of dextran sulfate. Pigs E and F were injected with T. gondii RH strain and 0.005 mg of dextran sulfate. Pigs G
and H were injected with only T. gondii RH strain. Pigs I and J were injected with only 0.5 mg of dextran sulfate
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Pathological analyses of experimental mice
The tail veins of four mice were injected with 2.5 mg,
250 μg, 25 μg, or 2.5 μg of DS10 or with PBS, respect-
ively, to analyze the toxic effects of intravenous injection
of DS10 to animals. Thus, we examined a total 20 mice
before performing the pig experiments with DS10. The
body weights of the mice were calculated every day
until autopsy at 5 days post-injection. The collected
samples were subjected to HE staining for histologic
examination.
Results
DS10 suppresses the symptoms of toxoplasmosis and
reduces parasite burden in organs
To analyze the toxic effects of intravenous DS injection
to animals, we performed pathological experiments with
20 mice before proceeding with DS experiments using
pigs. We found that mice intravenously administered DS
experienced neither significant weight loss nor patho-
logical effects (data not shown). We, therefore, pro-
ceeded with the pig experiments.
On the day of pig inoculation, the average body weight
of the ten experimental pigs was 4,199 g. All pigs in-
fected with T. gondii tachyzoites (pigs A, B, C, D, E, F, G
and H) showed symptoms 3–5 days after inoculation. In
contrast, no clinical signs were seen with the non-
infected pigs that were injected with DS10. The clinical
signs exhibited by the pigs that suffered from acute in-
fection with T. gondii were the characteristic signs of
fever, loss of appetite, sneezing, and unkempt fur. These
clinical signs were scored in the test pigs relative to the
symptoms of the control pigs (I and J). Of note, the pigs
that received the lowest dose of DS10 (5 μg per head)
showed similar signs to those exhibited by the RH-
infected control pigs (G and H), including fever (Fig. 1),
loss of appetite, shivering, unkempt fur, and tachypnea.
The clinical signs were less severe in the pigs that re-
ceived the higher doses of drug, and the one pig that re-
ceived the highest dose of drug (500 μg per head)
showed no symptoms. These results suggest that high-
dose DS10 suppressed the symptoms of toxoplasmosis.
We then quantified the parasite burden in various pig
organs by using qRT-PCR. Strikingly, all of the infected
pigs exhibited high parasite burden in the lung samples
but no parasites were found in the spleen or brain sam-
ples (Fig. 2). Parasites were detected in the liver and
lymph node samples of pigs E, F, G and H and in the
kidney samples of pigs G and H. These results indicate
that treatment with DS10 reduces T. gondii burden in
certain pig organs.
Next, we performed biochemical analyses of serum
samples collected from the pigs on day 5 post-infection
to assess the effects of treatment on organ function.
Serum levels of GOT, GPT, γGTP and TG (as indictors
of liver function) were within the normal ranges of
healthy pigs for all of the pigs tested. In contrast, the
serum CRE and BUN levels (as indicators of kidney
function) were slightly elevated in pigs G and H (data
a b
c d
Fig. 2 Parasite burden in the organs of individual pigs. Analyses of the relative expression of T. gondii 18S rRNA (by use of qRT–PCR) in liver
(a), lung (b), lymph nodes (c) and kidney (d). Results represent the expression of the 2ddCt parasite gene in pigs
Kato et al. Parasites & Vectors  (2016) 9:134 Page 4 of 9
not shown). These pigs exhibited symptoms of toxoplas-
mosis consistent with the high parasite burden in their
livers and kidneys.
Infection, but not treatment with DS, triggers
inflammatory responses in organs
Immunological responses were evaluated on day 5 post-
infection in serum for antibody responses, and in liver,
lungs, spleen, and lymph nodes for cytokine gene expres-
sion by using the latex agglutination test and qRT-PCR,
respectively. Notably, the antibody responses were below
the detection limits of the latex kit for all of the pig sera
tested (data not shown). Gene expressions for IFN-γ, IL-
12 and IL-6 were varied in the tested organs of the pigs;
however, these levels were relatively high in lymph nodes
and lungs as compared to those in livers (Fig. 3). These in-
creases seemed to be consistent with the elevated parasite
burden in lymph nodes and lungs. Control DS treated pigs
exhibited relatively lower expression of IFN-γ, IL-12 and
IL-6 cytokines in the lung and lymph nodes compared
with pigs infected with T. gondii (Fig. 3, panels A-H). In
contrast, IL-10 expression in liver and lymph nodes was
high in control DS treated pigs (Fig. 3, panels I and J), and
in lungs of pigs that received a lower dose of DS and no
treatment (Fig. 3, panels F-H). These data may suggest
that treatment with DS triggers only minor inflammatory
responses in the tested organs.
Treatment with DS alleviates hepatic and pulmonary
lesions caused by T. gondii infection
To gain further insights into the effects of DS on the
pathogenesis of T. gondii infection, we performed
histological analyses of the pigs’ spleen, liver, kidney,
lungs, lymph nodes, heart and brain. These histological
analyses revealed hepatic and pulmonary lesions, and
follicular reactions in the hilar lymph nodes.
Of note, multiple necrotic foci of hepatocytes with
aggregated inflammatory cells were observed in the TG
control and DS-L groups (Fig. 4a). The necrotic foci
became narrower in the DS-M group (Fig. 4b). In the
DS-H group, necrotic foci were not observed but a few
small nests of aggregated mononuclear cells were scat-
tered throughout the tissue (Fig. 4c). The inflammatory
foci were observed in all pigs and were clearly more
prevalent in T. gondii-infected pigs. T. gondii parasites
were often observed within the necrotic foci in the TG-
a b c
Fig. 3 Cytokines gene expression in tissues of pigs. Analyses of the relative expression of IFN-γ, IL-12, IL-6 and IL-10 (by use of qRT–PCR) in liver
(a), lung (b), and lymph nodes (c). Results represent the expression of the 2ddCt parasite gene in pigs
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control, DS-L, and DS-M groups, but they were obscure
in the HE specimen (Fig. 5a). No necrotic or inflammatory
foci were observed in the DS-control group, whereas
necrotic and/or inflammatory foci and reversible hepato-
cellular degeneration were observed in DS10-treated pigs.
In the DS-L group, a few mildly vacuolated hepatocytes
were observed at the peripheral zone of the lobule
(Fig. 4d). In the DS-M group, moderate vacuolar degener-
ation of hepatocytes at the peripheral zone of the lobule
was observed (Fig. 4e). In the DS-control and DS-H
groups, severe hydropic degeneration was observed in
almost all of the hepatocytes (Fig. 4f). No degenerative
changes were observed in the TG-control group. Objective
analyses of the hepatic lesions indicated that the necrotic
foci were most abundant in the DS-L group, and that their
numbers decreased as the dosage of DS10 increased.
In the lung, alveolar wall thickening due to mono-
nuclear cell infiltration was observed. In the TG-
control and DS-L groups, the lesions were moderate
and diffuse (Fig. 4g). Moderate to mild or diffuse
lesions were focally observed in the DS-M group
(Fig. 4h), whereas the lesions were slighter and
smaller in the DS-H group (Fig. 4i). Slight bronchitis
and bronchocentric infiltration of mononuclear cells
into the parenchyma were observed in all of the pigs
including the DS-control group.
Fig. 4 Histological features of the experimental pigs. Inflammatory and necrotic foci of liver (a–c), degenerative changes in hepatocytes (d–f) and
pulmonary inflammatory foci (g–i) were stained with hematoxylin and eosin. a Liver, pig E in the DS-L group. Focal necrosis of hepatocytes with
infiltrated inflammatory cells is evident. b Liver, pig D in the DS-M group. Similar necrotic and inflammatory foci as those shown in Fig. 4a can be
seen. Note that these foci are smaller than those of Fig. 4a. c Liver, pig A in the DS-H group. Focally aggregated inflammatory cells without
hepatocellular necrosis are shown. Hepatocellular degeneration is also evident. d Liver, pig F in the DS-L group. Mild vacuolar degeneration in a
few hepatocytes (arrows) at the periphery of the hepatic lobe are shown. e Liver, pig D in the DS-M group. The stronger degenerative changes
(arrows) were more frequently observed than those in Fig. 4d. f Liver, pig A in the DS-H group. Severe hepatocellular hydropic degeneration can
be seen throughout the hepatic lobe. CT denotes interlobular connective tissue, and CV denotes the central vein. g Lung, pig E in the DS-L
group. Extensive, moderately thickened alveolar wall due to infiltrated inflammatory cells was observed. h Lung, pig C in the DS-M group. The
area of thickened wall is smaller than that in Fig. 4g. i Lung, pig A in the DS-H group. Diffuse, apparently normal alveoli and limited wall thickening
were observed. Bars in a)–c) and f) represent 50 μm, bars in d) and e) represent 20 μm, and bars in g) and h) represent 200 μm
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Immunohistochemical analyses using the anti-T. gondii
antibody revealed that the suspected T. gondii-like or-
ganisms reacted positively. In addition, small granules
within hepatocytes and infiltrated macrophages were
found to give positive reactions. In the liver, the positive
reactions were mainly found within necrotic foci, but
were sometimes found within non-affected parenchyma
(Fig. 5b). In the lung, the positive reactions were found
within both the thickened alveolar wall and in non-
affected pulmonary parenchyma (Fig. 5c). No positive
reactions were detected in the DS-control group. The
number of positive reactions appeared to decrease as the
number of inflammatory or necrotic foci decreased in
the liver. The calculated positive reactions per unit area
in the liver decreased as the dosage of administered
DS10 increased, according to the histological observa-
tions (Fig. 6). In addition to the number of necrotic foci,
the number of positive reactions in the DS-L group was
greater than that of the TG-control group. The calculated
positive reactions per unit area in the lung also decreased
as the dosage of administered DS10 increased, according
to the histological observations (data not shown).
Discussion
Infected pigs and pork products are important sources
of T. gondii infection for humans and other animals.
The discovery and development of effective drugs to
treat these infections is therefore particularly important
Fig. 5 T. gondii organisms and immunohistochemical staining with an anti-T. gondii antibody. a Liver, pig E in the DS-L group. Slightly basophilic
oval organisms (arrows) in the cytoplasm of hepatocytes were stained with hematoxylin and eosin. b Necrotic liver foci, pig E in the DS-L group.
Positive reactions, stained brown, are scattered within the necrotic foci; non-affected parenchyma can be seen around the foci, as detected by
immunohistochemical staining. c Lung, pig E in the DS-L group. Positive reactions were scattered throughout the thickened alveolar wall, as
detected by immunohistochemical staining. Bar in a) represents 20 μm and bars in b) and c) represent 50 μm
Fig. 6 Necrotic, inflammatory foci, and positive reactions per unit area. The number of necrotic foci per square centimeter in the liver of each
experimental pig was calculated and is shown as the left-hand bar (A and B, DS-H group; C and D, DS-M group; E and F, DS-L group; G and F,
TG-control group; I and J, DS-control group). The number of inflammatory foci per square centimeter in the liver of each experimental pig was
also calculated and is shown as the middle bar. The average number of immuno-positive reactions against the anti-T. gondii antibody per square
centimeter in the liver of each experimental pig was calculated and is shown as the right-hand bar. Data represent the observations of two
independent investigators
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for the pork industry [2]. In the present study, we evalu-
ated the effects of intravenous administration of DS10 to
pigs experimentally infected with T. gondii. Treatment
with various doses of DS10 was effective in reducing the
clinical symptoms and parasite burden in the organs of
the infected pigs. These results are consistent with our
previous data showing that DS10 inhibits the growth of
parasites in vitro and in vivo in a mouse model [15].
One possible explanation for our findings is that DS10
restricted the growth of the parasite in the lungs and
thus prevented its spread to other organs. Indeed, previ-
ous studies have shown that lung is the first organ that
is preferably invaded by T. gondii in experimental infec-
tions [16, 17]. Moreover, a related study showed that
parasite burden is highest in the brain tissue followed by
lungs and muscles in pigs after experimental infection
[17]. The absence of parasite burden in the brain tissue
in our study probably reflects the date of sampling
(5 days post-infection). When we sampled later in the
previous experiment, we detected parasites in this tissue.
In this study, we administered DS intravenously, which
is not the route of drug administration that is widely
utilized in animal husbandry. So, we need additional
experiments to determine how effective oral administra-
tion would be against infection. Likewise, we only tested
the effect of DS on the acute infection. Experiments on
chronic infection would be needed when we foresee the
real world usage of this treatment.
Our analysis of mRNA cytokine profiles revealed that
the up-regulation in gene expression of pro-inflammatory
cytokines was consistent with the elevated parasite burden
in the lymph nodes and lungs of the pigs. Moreover, low
IL-10 gene expression was detected in all studied pigs. In
general, experimental infections with T. gondii elicit a
dominant Th1 response, characterized by high production
of IFN-γ and IL-12 during the acute stage of the infection,
and Th2-associated cytokines, such as IL-4 and IL-10,
which appear relatively late in infection to limit immune
pathology [18–20].
In the current study, histopathological lesions were
observed in the liver and lungs of all of the T. gondii-in-
fected pigs; multi-focal necrotic foci and inflammatory
foci in the liver as well as interstitial pneumonia were
observed. These lesions were similar to those previously
reported in naturally infected pigs [2, 21, 22]. Generally,
experimental T. gondii infection rarely causes histopatho-
logical lesions in pigs [3, 5, 7, 9, 23], and only one report
has described necrotic or inflammatory lesions of visceral
organs [6]. T. gondii parasites were immunohistochemi-
cally detected in the liver and lungs, mainly within the
lesions. Taken together, our data suggest that infection of
juvenile piglets via intravenous administration of T. gondii
provides a relevant model for investigating acute phase
infection, producing similar pathological lesions to those
observed in natural infections. The severity of the hepatic
and pulmonary lesions and the amount of detected T.
gondii antigen were remarkably different among animals
and dependent on the injected dosage of DS10. Severe
lesions and high parasite burdens were observed in pigs
that received low-dose DS10, but the number of lesions
and the burden gradually decreased as the dosage of the
drug was increased. These results demonstrate that it is
important to dose DS10 appropriately to obtain its inhibi-
tory effect on T. gondii growth in pigs. Moreover, DS10
exhibited its degenerative effects on pig hepatocytes in a
dose-dependent manner, suggesting that high-dose DS10
may require strict attention to limit its side effects. No
inflammatory changes were detected in the colon despite
previous reports that oral administration of dextran in-
duces colitis in pigs [24]. Of note, Kim et al. [25] previ-
ously reported that intravenous injection of DS10 does
not trigger any signs of colitis. Any side effect of DS10 is
likely dependent on the dosage as well as the injection
route.
Conclusion
Our study revealed that DS10 is a promising agent for
the treatment of toxoplasmosis, although high doses can
cause adverse effects on hepatic cells in pigs. Our data
suggest that a dose of approximately 0.05 mg of DS10
per average body weight of 4,199 g is an effective dose
for swine because it led to minimal clinical symptoms of
T. gondii infection and caused little hepatocellular
degeneration in our pig model. In this study it is possible
to potentially reduce parasite burden and cytokine
up-regulation but further work is necessary to identify
the drug targets or future inhibitors. These data
should be very beneficial to those interested in the
control of toxoplasmosis in pigs.
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